| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 57.4493 | 62 |
| GSM780708 | Untreated after 4 days (C2_1) | 55.2546 | 60 |
| GSM780709 | Untreated after 4 days (C3_1) | 57.9422 | 63 |
| GSM780719 | Untreated after 4 days (C1_2) | 51.9213 | 54 |
| GSM780720 | Untreated after 4 days (C2_2) | 55.1118 | 60 |
| GSM780721 | Untreated after 4 days (C3_2) | 62.476 | 66 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 51.9017 | 54 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 56.9499 | 62 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 48.0865 | 41 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 66.8885 | 68 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 56.8646 | 62 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 57.5546 | 62 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 64.1398 | 67 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 50.2276 | 49 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 58.3579 | 63 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 67.0291 | 68 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 55.8145 | 61 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 50.5621 | 50 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 64.8342 | 67 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 50.6038 | 50 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 55.9842 | 61 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 57.6278 | 63 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 55.3414 | 60 |